![L. Gordon Letts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
L. Gordon Letts
No open positions remaining
Profile
L.
Gordon Letts is Senior Vice President of Research and Development for Magen BioSciences, Inc. He was Senior Vice President of Research and Development and Chief Scientific Officer for NitroMed.
Prior to his current position, Dr. Letts was Chief Scientific Officer and Senior Vice President of Research and Development for NitroMed.
He was Director of Pharmacology for Boehringer Ingelheim Pharmaceuticals, Senior Research Scientist of Merck Frosst Canada, and Senior Scientist of Royal College of Surgeons of England.
Dr. Letts was President of the International Association of Inflammation.
He has experience in research and development and leadership.
Dr. Letts received a BS degree from Monash University and a PhD from Sydney University.
Former positions of L. Gordon Letts
| Companies | Position | End |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Chief Tech/Sci/R&D Officer | 21/05/2007 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/01/1993 |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Chief Executive Officer | - |
Inflammation Research Association, Inc.
 Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology | President | - |
Royal College of Surgeons
 Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Chief Tech/Sci/R&D Officer | - |
Training of L. Gordon Letts
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
NetMed, Inc.
 NetMed, Inc. Medical SpecialtiesHealth Technology Engages in the research and development activities | Health Technology |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
TargAnox, Inc.
TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Inflammation Research Association, Inc.
Inflammation Research Association, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology | Commercial Services |
- Stock Market
- Insiders
- L. Gordon Letts
